Features  |   May 2016
How Market Forces Can Affect Patient Safety: The Unintended Consequences of Capitalism in the Generic Drug Market
Author Affiliations
  • Roy G. Soto, M.D.
    Committee on Patient Safety and Education
  • Richard D. Urman, M.D., M.B.A.
    Committee on Patient Safety and Education
Article Information
Ethics / Medicolegal Issues / Patient Safety / Features
Features   |   May 2016
How Market Forces Can Affect Patient Safety: The Unintended Consequences of Capitalism in the Generic Drug Market
ASA Monitor 05 2016, Vol.80, 28-29.
ASA Monitor 05 2016, Vol.80, 28-29.
First off, let’s agree on two basic concepts: capitalism is good and patient safety is good. For decades we have been tempted with a never-ending parade of new, expensive devices and medications that are touted to improve safety and outcomes. Sometimes the acquisition cost is justified, and sometimes it’s not. Fortunately our clinical experience, common sense and pharmacoeconomic literature generally help us to determine when global value exceeds (or at least meets) cost. We perform a cost/benefit analysis and provide the best care for our patients using appropriate resources. In other words, we provide value-based care based on sound economic principles.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×